Driven by excellence, focused on strategies for the longer term.

This is the crux of who we are. It is an articulation of precision in purpose, from the Firm’s beginnings to where we are today. Our collective eye is unerringly trained on tomorrow.

Deep sectoral expertise across services and industries.

Our insistence on strategic advisory exacts an in-depth understanding of and involvement with our clients’ businesses and industries. We engage not just individual businesses, but also contribute to the country’s legal and regulatory frameworks.

Personal commitment supported by experience and grit.

We commit early. We pull together internally for greater support. Every effort is sincere, every individual deeply dedicated to their task, their role, to the Firm.

Our undertakings for long-term impact are an organic extension of our purpose.

They are to employ our deep knowledge of the law beyond the business, the transaction, the deal. To use the opportunities and skills we possess, to reflect on the culture we’re creating. Individually and collectively, these are our efforts to help shape the thinking of our future generations, and arm them with strategies for true, sustainable growth.

Knowledge-sharing is intrinsic to equity and inclusivity.

This is a repository of thought leadership, deep insights and strong viewpoints, legal and other news and events and how they impact the industry and our clients.

Relevance is critical to growth. It necessitates a firm that is dynamic and responsive.

Amplifying intrinsic talent, sharpening skills, expanding knowledge, is vital to leading. It defines every aspect of how our firm functions and transacts. This is how we create new benchmarks and set industry standards.

left arrow Sep 10, 2026

Mankind Pharma Limited on its business reorganization, involving the voluntary liquidation of Bharat Serums and Vaccines Limited and the distribution of its entire business to Mankind Pharma, its holding company.

AZB & Partners advised Mankind Pharma Limited on its business reorganization, involving the voluntary liquidation of Bharat Serums and Vaccines Limited and the distribution of its entire business to Mankind Pharma, its holding company.

The deal team comprised our Senior Partners Nilang Desai and Vaidhyanadhan Iyer; Partner Avinash Subramanian; along with Senior Associate Shivani Shenoy; and Associates Abhinav Shankarraman and Aashirwa Baburaj. The litigation aspects were supported by Partner Mrinal Shankar and Associate Abhay Shetty.

AUTHORS & CONTRIBUTORS

TAGS

SHARE

Subscribe

DISCLAIMER

These are the views and opinions of the author(s) and do not necessarily reflect the views of the Firm. This article is intended for general information only and does not constitute legal or other advice and you acknowledge that there is no relationship (implied, legal or fiduciary) between you and the author/AZB. AZB does not claim that the article's content or information is accurate, correct or complete, and disclaims all liability for any loss or damage caused through error or omission.

RELATED READING

Deals

Mankind Pharma Limited on its business reorganization, involving the voluntary liquidation of Bharat Serums and Vaccines Limited and the distribution of its entire business to Mankind Pharma, its holding company.
Sep 10, 2026 | Pharmaceuticals Healthcare & Life Sciences Restructuring
Deals

LG Electronics Inc., Korea, in proceedings before the Income Tax Appellate Tribunal, Delhi.
Sep 08, 2026 | Dispute Resolution
Deals

Gentari (formerly Amplus) on drafting, negotiating and successfully executing a comprehensive suite of project contracts, on a split structure basis, for its 69 MW wind power projects in Maharashtra.
Sep 04, 2026 | Energy Infrastructure